Bio-Works Technologies AB (1BD) Stock Statistics & Valuation Metrics

Bio-Works Technologies AB has a market cap or net worth of €28.61M. The enterprise value is €178.65M.

Bio-Works Technologies AB has 99,424,590 shares outstanding. The number of shares has decreased by -2.65% in one year.

Bio-Works Technologies AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Bio-Works Technologies AB is ―. Bio-Works Technologies AB’s PEG ratio is ―.

In the last 12 months, Bio-Works Technologies AB had revenue of ― and earned -12.94M in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Bio-Works Technologies AB pays an annual dividend of ―, resulting in a dividend yield of ―

Bio-Works Technologies AB upcoming earnings date is Aug 21, 2026, TBA (Confirmed).

Bio-Works Technologies AB as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Bio-Works Technologies AB has paid ― in taxes.

Bio-Works Technologies AB EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Bio-Works Technologies AB has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Bio-Works Technologies AB is ―, which is 11.43% higher than the current price. The consensus rating is ―